Press release
Myositis Clinical Trials, Pipeline Insights, and Companies 2024
Myositis Pipeline
Request a sample and discover the recent advances in Myositis Treatment Drugs @ Myositis Pipeline Report- https://www.delveinsight.com/report-store/myositis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Myositis Pipeline Report
• July 2024:- Argenx- A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Empasiprubart in Adults With Dermatomyositis. This study will evaluate the safety and efficacy of empasiprubart compared with placebo in adult participants with dermatomyositis (DM).
• July 2024:- Cabaletta Bio-A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Idiopathic Inflammatory Myopathy. RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy
• DelveInsight's Myositis pipeline report depicts a robust space with 20+ active players working to develop 22+ pipeline therapies for Myositis treatment.
• The leading companies working in the Myositis Market include Pharmaceuticals, Janssen Research & Development, LLC, Pfizer, Abcuro, Inc., Orphazyme, Bristol-Myers Squibb, Kezar Life Sciences, Inc., Horizon Therapeutics, Paean Biotechnology Inc., Alexion Pharmaceuticals, ImmunoForge, JN Biosciences, Merck KGaA, and others.
• Promising Myositis Pipeline Therapies in the various stages of development includes ABC008, Daxdilimab, BYM338 (Bimagrumab), BYM338, Arimoclomol, Nipocalimab, Glucocorticoids, and others.
The Myositis pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage Myositis drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the Myositis clinical trial landscape.
Find out more about Myositis Treatment Landscape @ Drugs for Myositis Treatment- https://www.delveinsight.com/sample-request/myositis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Myositis Emerging Drugs Profile
• Lenabasum: Corbus Pharmaceuticals
• Nipocalimab: Janssen Research & Development, LLC
Myositis Pipeline Therapeutics Assessment
There are approx. 20+ key companies which are developing the therapies for Myositis. The Myositis companies which have their Myositis drug candidates in the most advanced stage, i.e. phase III include, Corbus Pharmaceuticals.
Learn more about the emerging Myositis Pipeline Therapies @ Myositis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/myositis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Myositis Pipeline Report
• Coverage- Global
• Allergic Conjunctivitis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Allergic Conjunctivitis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Myositis Companies- Corbus Pharmaceuticals, Janssen Research & Development, LLC, Pfizer, Abcuro, Inc., Orphazyme, Bristol-Myers Squibb, Kezar Life Sciences, Inc., Horizon Therapeutics, Paean Biotechnology Inc., Alexion Pharmaceuticals, ImmunoForge, JN Biosciences, Merck KGaA, and others.
• Myositis Pipeline Therapies- ABC008, Daxdilimab, BYM338 (Bimagrumab), BYM338, Arimoclomol, Nipocalimab, Glucocorticoids, and others.
Dive deep into rich insights for new drugs for Myositis Treatment, Visit @ Myositis Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/myositis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Myositis: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Myositis - DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Lenabasum: Corbus Pharmaceuticals
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Nipocalimab: Janssen Research & Development, LLC
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. Drug Name: Company Name
15. Drug profiles in the detailed report…..
16. Inactive Products
17. Myositis Key Companies
18. Myositis Key Products
19. Myositis- Unmet Needs
20. Myositis- Market Drivers and Barriers
21. Myositis- Future Perspectives and Conclusion
22. Myositis Analyst Views
23. Myositis Key Companies
24. Appendix
For further information on the Myositis Pipeline therapeutics, reach out to Myositis Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/myositis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Top Selling Market Research Report in 2024
Brucellosis Market- https://www.delveinsight.com/report-store/brucellosis-market
Pacemakers Market- https://www.delveinsight.com/report-store/pacemakers-market
Surgical Energy Instruments Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Intraocular Lymphoma Market- https://www.delveinsight.com/report-store/intraocular-lymphoma-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Transcatheter Heart Valve Replacement Devices Market- https://www.delveinsight.com/report-store/transcatheter-heart-valve-replacement-devices-market
Endoscopic Ultrasound Market- https://www.delveinsight.com/report-store/endoscopic-ultrasound-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Trichomoniasis Market- https://www.delveinsight.com/report-store/trichomoniasis-market-insights
Radiodermatitis Market- https://www.delveinsight.com/report-store/radiodermatitis-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
CXCR Inhibitors Market- https://www.delveinsight.com/report-store/c-x-c-chemokine-receptor-inhibitors-competitive-landscape-market-and-pipeline-analysis
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Pigment Epithelial Detachment Market- https://www.delveinsight.com/report-store/pigment-epithelial-detachment-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
UK Healthcare Report- https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
About DelveInsight
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myositis Clinical Trials, Pipeline Insights, and Companies 2024 here
News-ID: 3658567 • Views: …
More Releases from DelveInsight Business Research LLP
Adenovirus Infections Market to Rise by 2032 | Tianjin CanSino Biotechnology, Ku …
DelveInsight's "Adenovirus Infections Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adenovirus Infections, historical and forecasted epidemiology as well as the Adenovirus Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Adenovirus Infections market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Adenovirus Infections market size…
Chemotherapy Induced Neutropenia Market Size is Set for Rapid Growth as Innovati …
The market size of Chemotherapy Induced Neutropenia is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Amgen, Amgen/Kyowa Hakko Kirin Co., Ltd., Teva B.V., G1 Therapeutics, Spectrum Pharmaceuticals, Enzychem Lifesciences Corporation, Aileron Therapeutics, Cellerant Therapeutics, Myelo therapeutics, BeyondSpring Pharmaceuticals, Evive Biotech.
[Nevada, United States] - DelveInsight's "Chemotherapy Induced Neutropenia Market Insights, Epidemiology, and Market Forecast 2032."…
Acute Unilateral Vestibulopathy Market to Rise by 2032 | Sensorion Pharma, and o …
DelveInsight's "Acute Unilateral Vestibulopathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Acute Unilateral Vestibulopathy, historical and forecasted epidemiology as well as the Acute Unilateral Vestibulopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Acute Unilateral Vestibulopathy market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
Acute Social Anxiety Disorder Market to Rise by 2034 | Vistagen Therapeutics, Bi …
DelveInsight's "Acute Social Anxiety Disorder Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Acute Social Anxiety Disorder, historical and forecasted epidemiology as well as the Acute Social Anxiety Disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Acute Social Anxiety Disorder market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
More Releases for Myositis
Myositis Treatment Market 2021 Valuable Growth Prospects and Upcoming Trends til …
An in-depth analysis of factors influencing the investment is also provided in the credible Myositis Treatment Market report which forecasts impending opportunities for the businesses and develops the strategies to improve return on investment (ROI). The purpose of market report is to provide a detailed analysis of Myositis Treatment Market and its impact based on applications and on different geographical regions. This market document encompasses a chapter on the global…
Inclusion Body Myositis (IBM) Therapeutics Development Market: Arimoclomol Emerg …
Rising instances of musculoskeletal diseases pertaining to autoimmune diseases such as inclusion body myositis (IBM) has instigated significant advancements in inclusion body myositis therapeutics development. An increase in global geriatric population is accounted as potent initiator of IBM which often targets elderly population, characterized by acute muscle weakness of the limbs. A new research report titled, 'Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018' added to the vast repository…
Global Inclusion Body Myositis Market Value 2018-2023 Orphazyme, Acceleron Pharm …
A market study "Global Inclusion Body Myositis Market" examines the performance of the Inclusion Body Myositis market 2018. It encloses an in-depth Research of the Inclusion Body Myositis market state and the competitive landscape globally. This report analyzes the potential of Inclusion Body Myositis market in the present and the future prospects from various angles in detail.
The Global Inclusion Body Myositis Market 2018 report includes Inclusion Body Myositis market Revenue,…
Recent Study Explores Fibrodysplasia Ossificans Progressiva (Myositis Ossificans …
Overview
Fibrodysplasia ossificans progressiva (FOP) is a disorder in which muscle tissue and connective tissue such as tendons and ligaments are gradually replaced by bone (ossified), forming bone outside that constrains movement. Symptoms swellings in fibrous tissue, pain, fever, muscle ossification and restricted movement of joints. Treatment includes surgery and medications to help relieve symptoms of FOP, such as pain and inflammation.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740072-fibrodysplasia-ossificans-progressiva-myositis-ossificans-progressiva-pipeline-review-h2-2017
Report Highlights
The Pharmaceutical and…
Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Clinic …
Market Research HUB's latest Pharmaceutical and Healthcare disease pipeline guide Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H1 2017, provides an overview of the Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal Disorders) pipeline landscape.
Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1196670
Fibrodysplasia Ossificans Progressiva (FOP) is a disorder in which muscle tissue and connective tissue such as tendons and ligaments are gradually replaced by bone (ossified), forming bone outside that constrains movement.…
Inclusion Body Myositis (IBM) - Pipeline Review And Industry Insight Report 2017
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Inclusion Body Myositis (IBM) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Inclusion Body Myositis (IBM) (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and…
